BD (Becton, Dickinson and Company) announces that it has received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the Food and Drug Administration (FDA) for the BD Veritor System for rapid detection of Flu A+B. This is the first rapid influenza test system that incorporates a digital read-out of results to receive CLIA waiver.
The BD Veritor System delivers very good analytical sensitivity and specificity, offering healthcare professionals a new and different option in rapid influenza testing versus current visually read CLIA-waived assays. The BD Veritor System provides objective results on an easy to read digital display, unlike current CLIA-waived rapid influenza tests, which require a subjective visual test interpretation to determine a positive or a negative test result.
The new BD Veritor System provides a new approach for CLIA-waived rapid tests for influenza A+B by offering a combination of speed, accuracy and convenience with an objective read that physicians can trust, says Tom Polen, president of BD Diagnostics Diagnostic Systems. We believe the BD Veritor System has the potential to change the way doctors view in-office rapid flu testing.
The BD Veritor System rapid flu immunoassay reports performance measured against polymerase chain reaction (PCR) results, the highest sensitivity standard currently available. This newly designed system incorporates BDs novel Nano Detection Particle and Adaptive Read Technology. With this unique combination of technologies in a CLIA-waived Flu assay, the BD Veritor System offers users a convenient workflow; just a few, easy steps requiring very little sample preparation; no sample incubation required prior to running the test; and a 10-minute period for the test to run and ten seconds of instrument read for final results.
The assay for rapid detection of Flu A+B on the BD Veritor System represents the first of many different assays that are planned on this new platform.
For more information on the BD Veritor System, visit http://www.bd.com/ds/veritorsystem.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.